In this review:
Treatment options for plasmablastic lymphoma
Device for cryoprevention of oral mucositis
Infectious complications in acute graft-versus-host disease
Brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma
Pembrolizumab vs brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma
T-cell lymphomas: real-world analysis from a cancer registry
Camrelizumab + apatinib for relapsed/refractory peripheral T-cell lymphoma
CD19/22 dual targeting CAR-T cell + pembrolizumab
Please login below to download this issue (PDF)